Literature DB >> 24111798

Unanswered questions in headache: so what is photophobia, anyway?

Andrew F Russo1, Ana Recober.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24111798      PMCID： PMC4013235          DOI： 10.1111/head.12231

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  15 in total

1.  Calcitonin gene-related peptide-like immunoreactivity marks putative visceral sensory pathways in human brain.

Authors:  S de Lacalle; C B Saper
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 2.  CGRP: sensory neuropeptide with multiple neurologic implications.

Authors:  Eduardo E Benarroch
Journal:  Neurology       Date:  2011-07-19       Impact factor: 9.910

3.  Central projections of melanopsin-expressing retinal ganglion cells in the mouse.

Authors:  Samer Hattar; Monica Kumar; Alexander Park; Patrick Tong; Jonathan Tung; King-Wai Yau; David M Berson
Journal:  J Comp Neurol       Date:  2006-07-20       Impact factor: 3.215

4.  Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus.

Authors:  Oliver Summ; Annabelle R Charbit; Anna P Andreou; Peter J Goadsby
Journal:  Brain       Date:  2010-09       Impact factor: 13.501

Review 5.  CGRP and its receptors provide new insights into migraine pathophysiology.

Authors:  Tony W Ho; Lars Edvinsson; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2010-09-07       Impact factor: 42.937

6.  Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats.

Authors:  Jeong S Han; Hita Adwanikar; Zhen Li; Guangchen Ji; Volker Neugebauer
Journal:  Mol Pain       Date:  2010-02-08       Impact factor: 3.395

7.  Intrinsically photosensitive retinal ganglion cells are the primary but not exclusive circuit for light aversion.

Authors:  Anna Matynia; Sachin Parikh; Bryan Chen; Paul Kim; David S McNeill; Steven Nusinowitz; Christopher Evans; Michael B Gorin
Journal:  Exp Eye Res       Date:  2012-10-16       Impact factor: 3.467

8.  Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.

Authors:  Ana Recober; Adisa Kuburas; Zhongming Zhang; John A Wemmie; Michael G Anderson; Andrew F Russo
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

9.  Bright light activates a trigeminal nociceptive pathway.

Authors:  Keiichiro Okamoto; Akimasa Tashiro; Zheng Chang; David A Bereiter
Journal:  Pain       Date:  2010-03-04       Impact factor: 7.926

10.  A neural mechanism for exacerbation of headache by light.

Authors:  Rodrigo Noseda; Vanessa Kainz; Moshe Jakubowski; Joshua J Gooley; Clifford B Saper; Kathleen Digre; Rami Burstein
Journal:  Nat Neurosci       Date:  2010-01-10       Impact factor: 24.884
View more
  5 in total

Review 1.  CGRP as a neuropeptide in migraine: lessons from mice.

Authors:  Andrew F Russo
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

2.  Photophobia and abnormally sustained pupil responses in a mouse model of bradyopsia.

Authors:  Adisa Kuburas; Stewart Thompson; Nikolai O Artemyev; Randy H Kardon; Andrew F Russo
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-25       Impact factor: 4.799

3.  Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.

Authors:  Anne-Sophie Wattiez; Levi P Sowers; Andrew F Russo
Journal:  Expert Opin Ther Targets       Date:  2020-02-13       Impact factor: 6.902

Review 4.  Calcitonin gene-related peptide (CGRP): a new target for migraine.

Authors:  Andrew F Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

5.  CGRP Administration Into the Cerebellum Evokes Light Aversion, Tactile Hypersensitivity, and Nociceptive Squint in Mice.

Authors:  Mengya Wang; Thomas L Duong; Brandon J Rea; Jayme S Waite; Michael W Huebner; Harold C Flinn; Andrew F Russo; Levi P Sowers
Journal:  Front Pain Res (Lausanne)       Date:  2022-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.